Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
Clinical trial NCT02785913 · COMPLETED
Trial details
- NCT number
- NCT02785913
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.